Stock Screener App

Free -

Install

0.1479

3.72% 0.0053

Viracta Therapeutics Inc (VIRX)

Overview News Price History Option Chain Financials Discussions Forecast

Viracta Therapeutics Inc Stock (VIRX) Financials Data

*All numbers in millions

Period End Date	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Period Length	3 Months	3 Months	3 Months	3 Months	3 Months
Revenues	-	-	-	-	-
Operating Expenses	2.32% 13.88	13.56	12.47	12.45	12.21
Interest Income/Expense	9.59% 0.858	0.949	0.953	0.921	0.88
Operating Income/Loss	2.32% -13.88	-13.56	-12.47	-12.45	-12.21
Income/Loss From Continuing Operations Before Tax	33.59% -9.141	-13.77	-12.60	-12.48	-12.21
Income/Loss From Continuing Operations After Tax	33.59% -9.141	-13.77	-12.60	-12.48	-12.21
Net Income/Loss	33.59% -9.141	-13.77	-12.60	-12.48	-12.21
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	70,188% 39.32	0.0559	38.68	38.56	38.46
Diluted Average Shares	70,188% 39.32	0.0559	38.68	38.56	38.46
Basic Earnings Per Share	34.29% -0.23	-0.35	-0.33	-0.32	-0.32
Diluted Earnings Per Share	34.29% -0.23	-0.35	-0.33	-0.32	-0.32
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

SMMT

$18.94

1.35%

INCY

$75.45

0.87%

MRNA

$43.39

3.19%

UTHR

$378.13

0.30%

BGNE

$206.16

7.31%

BNTX

$120.72

1.84%

Open in Yahoo | Open in Google | Open in Finviz | Open in MarketWatch | Open in EDGAR | Open in Reuters